Results 201 to 210 of about 71,029 (345)

Paediatric‐type nodal follicular lymphoma in a child diagnosed with chronic myeloid leukaemia [PDF]

, 2019
Nerea Domínguez‐Pinilla, Elena Martínez‐Zamorano, Yolanda Campos‐Martín, Patrocinio Algara Plana, Luis Ignacio González‐Granado, Marcos Zamora Gómez, Manuela Mollejo Villanueva   +6 more
openalex   +1 more source

Bioinformatics differential expression analysis of the effect of cannabidiol in chronic myeloid leukaemia cell line. [PDF]

Glob Med Genet
Donchev PP, Danova ST.
europepmc   +1 more source

Survival with chronic myeloid leukaemia after failing milestones. [PDF]

Leukemia, 2023
Lauseker M, Hehlmann R, Hochhaus A, Saußele S.   +3 more
europepmc   +1 more source

Management of chronic myeloid leukaemia [PDF]

European Journal of Haematology, 1986
openaire   +3 more sources

Assessment of critical survival mechanisms exploited by BCR-ABL1+ cells to evade tyrosine kinase inhibitor-induced death: determination of novel therapeutic targets in chronic myeloid leukaemia.

, 2014
Lisa Schafranek
openalex   +1 more source

Efficacy of Phytochemicals of Cassia Angustifolia in Chronic Myeloid Leukaemia – An In-silico Analysis

, 2023
Faisal Mehmood
openalex   +1 more source

Atypical Wounds in Chronic Graft‐Versus‐Host Disease and Peripheral Arterial Disease Caused by Tyrosine Kinase Inhibitors

JEADV Clinical Practice, EarlyView.
ABSTRACT The term “atypical wounds” primarily refers to lesions with immunological or cancerous etiologies. However, these wounds can also be drug‐induced. We report about a 32‐year‐old man with a 6‐year history of chronic myelogenous leukemia (CML) and chronic graft‐versus‐host disease (cGvHD) following an HLA‐compatible allogeneic stem cell ...
E. K. Stuermer, K. Malik, C. Willers, M. Augustin   +3 more
wiley   +1 more source

Changes in Common Blood Parameters After Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukaemia. [PDF]

EJHaem
Fernando F, Wasko C, Johns B, Claudiani S, Khan A, Innes AJ, Milojkovic D, Apperley JF.   +7 more
europepmc   +1 more source

Unveiling the interplay: chronic myeloid leukaemia and diabetic proliferative retinopathy in a challenging case. [PDF]

BMJ Case Rep, 2023
Ger M, Mandal S, Padhy SK, Sahu S.
europepmc   +1 more source

Additional file 2 of The effects of combination treatments on drug resistance in chronic myeloid leukaemia: an evaluation of the tyrosine kinase inhibitors axitinib and asciminib

, 2020
H. Jonathan G. Lindström, Ran Friedman
openalex   +1 more source